𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A case of Behçet’s disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab

✍ Scribed by Toru Hirano; Nobuyuki Ohguro; Satoshi Hohki; Keisuke Hagihara; Yoshihito Shima; Masashi Narazaki; Atsushi Ogata; Kazuyuki Yoshizaki; Atsushi Kumanogoh; Tadamitsu Kishimoto; Toshio Tanaka

Book ID
113057880
Publisher
Springer
Year
2011
Tongue
English
Weight
275 KB
Volume
22
Category
Article
ISSN
1439-7595

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tocilizumab, a humanized anti-interleuki
Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for the treatment of autoimmune disorders
✍ Toshio Tanaka; Keisuke Hagihara; Yoshihito Shima; Masashi Narazaki; Atsushi Ogat 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

## Abstract The cytokine interleukin (IL)‐6 has a wide range of biological activities. It contributes to host defense against pathogens by inducing immune responses, hematopoiesis, and acute‐phase reactions. However, dysregulation of IL‐6 production plays a significant pathological role in various

Successful use of a humanized anti–inter
Successful use of a humanized anti–interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis
✍ Yasuaki Okuda; Kiyoshi Takasugi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 329 KB 👁 2 views

## Abstract We report an excellent clinical response to treatment with a humanized anti–interleukin‐6 receptor antibody, tocilizumab, in a patient with progressive amyloid A (AA) amyloidosis complicating very active juvenile idiopathic arthritis. Treatment with tocilizumab immediately normalized th